Loading...
•
Sep 30, 2024
Encompass Health Q3 2024 Earnings Report
Encompass Health's third quarter performance was strong, with revenue and Adjusted EBITDA increasing.
Key Takeaways
Encompass Health Corporation reported strong results for the third quarter ended September 30, 2024. Revenue increased by 11.9% and Adjusted EBITDA increased by 13.4%. The company also increased its full-year guidance.
Revenue growth of 11.9% resulted primarily from discharge growth of 8.8%, including same-store growth of 6.8%. Net revenue per discharge grew 2.5%.
Cash flows provided by operating activities increased 24.4% to $267.8 million, primarily due to an increase in net income partly offset by higher cash tax payments.
Adjusted EBITDA increased 13.4%, primarily from increased revenue.
The Company increased its full-year guidance.
Encompass Health
Encompass Health
Forward Guidance
The Company increased its full-year guidance as follows:
Positive Outlook
- Net operating revenue: $5,325 to $5,375 million
- Adjusted EBITDA: $1,070 to $1,090 million
- Adjusted earnings per share from continuing operations attributable to Encompass Health: $4.19 to $4.33